Emillie Roger - Search Results

Year	Number of Results
2009	1
2010	2
2011	1
2012	2
2013	1
2014	1
2016	1
2017	4
2018	2
2019	2
2021	3
2022	4
2023	2
2024	0

1

FRET as the tool for in vivo nanomedicine tracking.

Kaeokhamloed N, Legeay S, Roger E. Kaeokhamloed N, et al. Among authors: roger e. J Control Release. 2022 Sep;349:156-173. doi: 10.1016/j.jconrel.2022.06.048. Epub 2022 Jul 7. J Control Release. 2022. PMID: 35779657 Free article. Review.

2

Advances in treatment formulations for acute myeloid leukemia.

Briot T, Roger E, Thépot S, Lagarce F. Briot T, et al. Among authors: roger e. Drug Discov Today. 2018 Dec;23(12):1936-1949. doi: 10.1016/j.drudis.2018.05.040. Epub 2018 Jun 2. Drug Discov Today. 2018. PMID: 29870791 Free article. Review.

3

Organic nanoparticle tracking during pharmacokinetic studies.

Bonnet S, Elfatairi R, Franconi F, Roger E, Legeay S. Bonnet S, et al. Among authors: roger e. Nanomedicine (Lond). 2021 Dec;16(28):2539-2536. doi: 10.2217/nnm-2021-0155. Epub 2021 Nov 24. Nanomedicine (Lond). 2021. PMID: 34814704

4

Models for drug absorption from the small intestine: where are we and where are we going?

Billat PA, Roger E, Faure S, Lagarce F. Billat PA, et al. Among authors: roger e. Drug Discov Today. 2017 May;22(5):761-775. doi: 10.1016/j.drudis.2017.01.007. Epub 2017 Jan 20. Drug Discov Today. 2017. PMID: 28115264 Review.

5

How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?

Malhaire H, Gimel JC, Roger E, Benoît JP, Lagarce F. Malhaire H, et al. Among authors: roger e. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):320-336. doi: 10.1016/j.addr.2016.03.011. Epub 2016 Apr 4. Adv Drug Deliv Rev. 2016. PMID: 27058155 Review.

6

Drug Delivery Systems for the Oral Administration of Antimicrobial Peptides: Promising Tools to Treat Infectious Diseases.

Deshayes C, Arafath MN, Apaire-Marchais V, Roger E. Deshayes C, et al. Among authors: roger e. Front Med Technol. 2022 Jan 25;3:778645. doi: 10.3389/fmedt.2021.778645. eCollection 2021. Front Med Technol. 2022. PMID: 35146486 Free PMC article. Review.

7

Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity.

Briot T, Roger E, Bou Haidar N, Bejaud J, Lautram N, Guillet C, Thépot S, Legeay S, Lagarce F. Briot T, et al. Among authors: roger e. Int J Nanomedicine. 2019 Mar 26;14:2091-2102. doi: 10.2147/IJN.S190482. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30988610 Free PMC article.

8

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far.

Clavreul A, Pourbaghi-Masouleh M, Roger E, Menei P. Clavreul A, et al. Among authors: roger e. Int J Nanomedicine. 2019 Apr 9;14:2497-2513. doi: 10.2147/IJN.S194858. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31040671 Free PMC article. Review.

9

The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.

Huynh NT, Roger E, Lautram N, Benoît JP, Passirani C. Huynh NT, et al. Among authors: roger e. Nanomedicine (Lond). 2010 Nov;5(9):1415-33. doi: 10.2217/nnm.10.113. Nanomedicine (Lond). 2010. PMID: 21128723 Review.

10

Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.

Lebreton V, Kaeokhamloed N, Vasylaki A, Hilairet G, Mellinger A, Béjaud J, Saulnier P, Lagarce F, Gattacceca F, Legeay S, Roger E. Lebreton V, et al. Among authors: roger e. J Control Release. 2022 Nov;351:681-691. doi: 10.1016/j.jconrel.2022.09.057. Epub 2022 Oct 7. J Control Release. 2022. PMID: 36191672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year